These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 634993)
1. Effect of the prolonged immunization with tumor-unrelated antigen on the tumor growth. Targowski SP; Albini B; Milgrom F Proc Soc Exp Biol Med; 1978 Mar; 157(3):511-6. PubMed ID: 634993 [No Abstract] [Full Text] [Related]
2. Effect of prolonged immunization of mice with bovine serum albumin on the incidence of chemically induced tumors. Targowski SP; Milgrom F Immunol Commun; 1980; 9(1):1-6. PubMed ID: 6988329 [TBL] [Abstract][Full Text] [Related]
4. Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice. Merino F; Abeyounis CJ; Milgrom F Eur J Cancer (1965); 1979 Jun; 15(6):829-35. PubMed ID: 499271 [No Abstract] [Full Text] [Related]
5. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma. Rogers MJ; Law LW Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307 [No Abstract] [Full Text] [Related]
6. [Antitumor resistance induced by immunization with normal definitive tissues]. Bodrova BL Tsitologiia; 1979 Nov; 21(11):1342-7. PubMed ID: 93333 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of tumor cells inactivated by heat. Suit HD; Sedlacek RS; Wiggins S Cancer Res; 1977 Oct; 37(10):3836-7. PubMed ID: 908025 [No Abstract] [Full Text] [Related]
8. Immunogenetic control of metastatic competence of cloned tumor cell populations. Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357 [No Abstract] [Full Text] [Related]
9. Competition for cytotoxic immune capacity against a 'syngeneic' mouse tumour distributed at two sites. Chassoux D; MacLennan IC; Munro TR Int J Cancer; 1977 Jun; 19(6):796-802. PubMed ID: 873644 [TBL] [Abstract][Full Text] [Related]
10. The effect of pregnancy on the growth of primary methylcholanthrene sarcoma isografts. McLaughlin AP; Effron MK J Surg Oncol; 1977; 9(2):107-10. PubMed ID: 865122 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation. Jurin M; Suit HD Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987 [No Abstract] [Full Text] [Related]
12. Receptor sites for antigen-antibody complexes on cells derived from solid tumors: detection by means of antibody sensitized sheep erythrocytes labeled with technetium-99m. Wood GW; Gillespie GY; Barth RF J Immunol; 1975 Mar; 114(3):950-7. PubMed ID: 1089728 [TBL] [Abstract][Full Text] [Related]
13. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production. Isakov N; Segal S; Hollander N; Feldman M Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490 [TBL] [Abstract][Full Text] [Related]
14. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells. Dei T; Tachibana T J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309 [TBL] [Abstract][Full Text] [Related]
15. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors. BasombrÃo MA; Prehn RT Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598 [No Abstract] [Full Text] [Related]
16. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts. Greene MI; Fujimoto S; Sehon AH J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667 [TBL] [Abstract][Full Text] [Related]
18. Tumour specific cell surface antigen and Forssman antigen associated with rat and hamster cells transformed with different strains of avian sarcoma virus. Aupoix MC; Simkovic D; Gazzolo L Neoplasma; 1973 May; 20(5):481-90. PubMed ID: 4356856 [No Abstract] [Full Text] [Related]
19. Immunotherapy of a murine sarcoma using specific antitumor immune RNA. Webster DJ; Cornacoff JB; Vallera DA; Dalmasso JP; Dodd MC; Minton JP J Surg Oncol; 1979; 12(3):213-20. PubMed ID: 502564 [TBL] [Abstract][Full Text] [Related]
20. Specific immunoprotection with 3 M KCl solubilized tumor antigen. Kahan BD; Pellis NR J Surg Res; 1975 Mar; 18(3):263-9. PubMed ID: 1134089 [No Abstract] [Full Text] [Related] [Next] [New Search]